| Geographical availability |
Afghanistan, Albania, Algeria, Altay, Amur, Andaman Is., Assam, Austria, Azores, Baleares, Baltic States, Bangladesh, Belarus, Belgium, Bulgaria, Canary Is., Cape Verde, Central European Rus, Chad, China North-Central, China South-Central, China Southeast, Chita, Corse, Cyprus, Czechoslovakia, Denmark, Djibouti, East Aegean Is., East European Russia, East Himalaya, Egypt, Eritrea, Ethiopia, Finland, France, Germany, Great Britain, Greece, Gulf States, Hungary, India, Inner Mongolia, Iran, Iraq, Ireland, Irkutsk, Italy, Japan, Kazakhstan, Khabarovsk, Kirgizstan, Korea, Krasnoyarsk, Kriti, Krym, Kuril Is., Kuwait, Laos, Lebanon-Syria, Libya, Madeira, Manchuria, Morocco, Myanmar, Nepal, Netherlands, Nicobar Is., North Caucasus, North European Russi, Northwest European R, Norway, Oman, Pakistan, Palestine, Poland, Portugal, Primorye, Romania, Sakhalin, Sardegna, Saudi Arabia, Selvagens, Sicilia, Sinai, South China Sea, South European Russi, Spain, Sudan, Sweden, Switzerland, Tadzhikistan, Taiwan, Thailand, Tibet, Transcaucasus, Tunisia, Turkey, Turkey-in-Europe, Turkmenistan, Ukraine, Uzbekistan, Vietnam, West Himalaya, West Siberia, Western Sahara, Yemen, Yugoslavia |
| Target gene or protein |
ABCG2, ADAM23, BRCA1, CCNA1, CSF1, EGF, EGFR, ESR2, GSTP1, IL-6, Notch1, SERPINE1, VEGFA, ABCB1, Bcl-2, CCND1, CDH13, ESR1, KRT19, PGR, PTG |
| Gene or Protein evidence |
Genes that were upregulated by more than 2-fold are ABCG2, ADAM23, BRCA1, CCNA1, CSF1, EGF, EGFR, ESR2, GSTP1, IL6, NOTCH1, SERPINE1 and VEGFA, and the genes that were down-regulated by more than 2-fold are ABCB1, BCL2, CCND1, CDH13, ESR1, KRT19, PGR, and PTGS2.
|